SEC and FDA Join Forces to Boost Market Integrity and Public Health

The Securities and Exchange Commission (SEC) has signed a Memorandum of Understanding (MOU) with the Food and Drug Administration (FDA) to enhance market integrity and public health.

This partnership aims to facilitate information sharing between the two agencies, improving the accuracy and timeliness of FDA-related disclosures. The MOU outlines collaboration on FDA-related disclosures to bolster investor protection and ensure fair, orderly, and efficient financial markets.

The SEC will gain access to the FDA's expertise and nonpublic information, allowing for more effective regulatory oversight in the financial sector. This move reflects a broader trend of regulatory bodies seeking to improve market integrity, particularly as the crypto market experiences mixed signals regarding investor sentiment.